Literature DB >> 11782015

The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross.

Asa C M Johansson1, Britt Nakken, Martin Sundler, Anna-Karin B Lindqvist, Martina Johannesson, Marta Alarcón-Riquelme, Anne Isine Bolstad, Michael G Humphreys-Beher, Roland Jonsson, Kathrine Skarstein, Rikard Holmdahl.   

Abstract

The non-obese diabetic (NOD) mouse spontaneously develops diabetes and sialadenitis. The sialadenitis is characterized by histopathological changes in salivary glands and functional deficit similar to Sjögren's syndrome. In humans, Sjögren's syndrome could be associated with other connective tissue disorders, such as rheumatoid arthritis. In the present study the genetic control of sialadenitis in mice was compared to that of arthritis. We have previously reported a NOD locus, identified in an F2 cross with the H2(q) congenic NOD (NOD.Q) and C57BL/10.Q (B10.Q) strains, that promoted susceptibility to collagen-induced arthritis. The sialadenitis in NOD.Q showed a similar histological phenotype as in NOD, whereas no submandibular gland infiltration was found in B10.Q. The development of sialadenitis was independent of immunization with type II collagen and established arthritis. To identify the genetic control of sialadenitis, a gene segregation experiment was performed on an (NOD.QxB10.Q)F2 cross and genetic mapping of 353 F2 mice revealed one significant locus associated with sialadenitis on chromosome 4, LOD score 4.7. The NOD.Q allele-mediated susceptibility under a recessive inheritance pattern. The genetic control of sialadenitis seemed to be unique in comparison to diabetes and arthritis, as no loci associated with these diseases have been identified at the same location.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782015     DOI: 10.1002/1521-4141(200201)32:1<243::AID-IMMU243>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Horizons in Sjögren's syndrome genetics.

Authors:  Pamela H Williams; Beth L Cobb; Bahram Namjou; R Hal Scofield; Amr H Sawalha; John B Harley
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  The genetics of primary Sjögren's syndrome.

Authors:  Amr H Sawalha; Robyn Potts; Wendi R Schmid; R Hal Scofield; John B Harley
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

3.  Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes.

Authors:  Gerard A J Morris; Christopher E Lowe; Jason D Cooper; Felicity Payne; Adrian Vella; Lisa Godfrey; John S Hulme; Neil M Walker; Barry C Healy; Alex C Lam; Paul A Lyons; John A Todd
Journal:  BMC Genet       Date:  2006-02-22       Impact factor: 2.797

Review 4.  Genetic aspects of Sjögren's syndrome.

Authors:  Anne I Bolstad; Roland Jonsson
Journal:  Arthritis Res       Date:  2002-09-24

5.  Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.

Authors:  Margaret K Gatumu; Kathrine Skarstein; Adrian Papandile; Jeffrey L Browning; Roy A Fava; Anne Isine Bolstad
Journal:  Arthritis Res Ther       Date:  2009-02-18       Impact factor: 5.156

6.  The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice.

Authors:  Trond Ove R Hjelmervik; Anna-Karin Lindqvist; Kjell Petersen; Martina Johannesson; Anne-Kristin Stavrum; Asa Johansson; Roland Jonsson; Rikard Holmdahl; Anne Isine Bolstad
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

7.  Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.

Authors:  Victor Matheu; Alexandra Treschow; Ingrid Teige; Vaidrius Navikas; Shohreh Issazadeh-Navikas
Journal:  Respir Res       Date:  2005-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.